Search clinical trials for: ONO-7475

Total 13110 results

University Hospital, Limoges

Completed

Treatement of Extension Fractures of the Distal Radius (fradius)

Fracture of Distal Radius

France
Yi Zhou

Recruiting

Clinical Comparison of On1 Two-stage Abutment With One-stage Abutment on Different Implant Neck Design

Implant Site Reaction

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

A Study of LP-168 in Participants With Relapse or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma (MCL)

China
EIP Pharma Inc
Amsterdam UMC, location VUmc; Worldwide Clinical Trials

Completed

Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease (REVERSE-SD)

Alzheimer Disease

United States, Netherlands, United Kingdom, Czechia, Denmark
University Hospital, Toulouse
Fondation Plan Alzheimer

Completed

Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients (VIP)

Alzheimer Disease

France
EIP Pharma Inc
Voisin Consulting, Inc.

Terminated

Within Subject Crossover Study of Cognitive Effects of Neflamapimod in Early-Stage Huntington Disease

Huntington Disease

United Kingdom
Göteborg University
The Sten A Olsson foundation for Research and Culture

Completed

The Effects of a Rhythm and Music-based Therapy Program and Therapeutic Riding in Late Recovery Phase Following Stroke

Stroke

Sweden
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Completed

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Lymphoma | Metastatic Melanoma | Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm and other conditions

United States
Ono Pharma USA Inc
Ono Pharmaceutical Co. Ltd

Completed

ONO-2952 Single-dose PET Study in Healthy Adult Subjects

Healthy Adult Subjects

United States
Merck Sharp & Dohme LLC

Completed

Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)

Merkel Cell Carcinoma

United States, Australia, Canada, France, Italy, New Zealand, Spain, Sweden
Sahlgrenska University Hospital, Sweden
BioGaia AB

Completed

Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri (ELBOWII)

Postmenopausal Osteoporosis

Sweden
University Hospital of Cologne

Completed

App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season

Allergic Rhinitis

Germany
Ono Pharmaceutical Co. Ltd

Recruiting

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Relapsed or Refractory T Cell Lymphoma

United States
Neuromed IRCCS

Unknown

Action Observation Treatment (AOT) as a Rehabilitation Tool (AOT)

Stroke, Acute Hemiplegia, Apraxia

Italy
Zagazig University

Not yet recruiting

Novel Technique Lumber Spine Fusion: Unilateral Pedicular Screws Fixation Combined With Contralateral Interbody Cage

Treatment
Takeda

Terminated

Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia

Hypercholesterolemia

United States
Guangzhou Lupeng Pharmaceutical Company LTD.

Completed

A Food Effect Study of LP-168 Tablets in Healthy Subjects

Mantle Cell Lymphoma

China
Takeda

Terminated

Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia

Hypercholesterolemia

Ukraine, Spain, Israel, Netherlands, Estonia, Russian Federation, Hungary, Norway, United Kingdom, Slovakia, Latvia
Spine Care, Oklahoma

Completed

Lead Migration in Spinal Cord Stimulation Trials: Comparing Non-suture vs Suture and Lead Anchor

Spinal Cord Stimulation

United States
Takeda

Completed

Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol

Dyslipidemia

United States
Ono Pharmaceutical Co. Ltd

Suspended

Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685

Plaque Psoriasis

United Kingdom, Moldova, Republic of, Romania
Sahlgrenska University Hospital, Sweden
Medical University of Vienna

Completed

Obeticholic Acid in Bariatric and Gallstone Disease (OCABSGS)

Obesity | Gallstones

Sweden
Ono Pharmaceutical Co. Ltd

Terminated

A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers

Acromegaly

United States
University of Alabama at Birmingham
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Cardiometabolic Health Intervention Using Movement-to-Music Exercise (CHIME)

Cardiometabolic Risk Factors in Adult Wheelchair Users

United States
Boston Medical Center

Completed

Improving Performance of Paracentesis in Medical Residency Training

Cirrhosis | Ascites

United States
Texas Tech University Health Sciences Center

Completed

Low Starch Dietary Education Program vs. Traditional Treatment for PCOS

Nutrition Disorders | Diet Modification | PCOS | Metabolism

United States
Alume Biosciences, Inc.
Ergomed

Recruiting

Feasibility Study- REVEAL 475 for Bevonescein-Assisted Nerve Visualization in Head & Neck Surgery

Head and Neck Surgery

United States
Amgen

Withdrawn

AMG 745 in Subjects With Age-associated Muscle Loss

Age-associated Muscle Loss
Hospital de Clinicas de Porto Alegre

Completed

Adolescent Mothers, Grandmothers, Breastfeeding and Complementary Feeding

Weaning | Breastfeeding

Brazil
University of Oslo
University of Tromso; University of Minnesota; Boots Norway AS; Mills DA

Unknown

Vascular Lifestyle-Intervention and Screening in Pharmacy (VISA)

Cardiovascular Diseases | Diabetes Mellitus, Type 2 | Dyslipidemia | Hypercholesterolemia | Hypertensive Disease

Norway
Yipeng Liu

Active, not recruiting

Expression Analysis of Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of Its Clinical Diagnostic Value

Diabetic Nephropathy

China
Shirley Ryan AbilityLab

Completed

Walk Assist Device to Improve Community Ambulation

Stroke

United States
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

Overactive Bladder
Ono Pharma USA Inc

Completed

Single Dose Escalation Study of ONO-9054 in Healthy Volunteers

Healthy Adult Subjects

United States
Ono Pharmaceutical Co. Ltd

Completed

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

Overactive Bladder
Yipeng Liu

Active, not recruiting

Expression Analysis of Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation of Its Clinical Diagnostic Value

Diabetic Nephropathy

China
Yipeng Liu

Active, not recruiting

The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD

Diabetic Nephropathies | Thromboembolism | Glomerulonephritis, Membranous | Thrombelastography

China
Astellas Pharma Inc
Ono Pharmaceutical Co. Ltd

Completed

ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients

Osteoporosis | Bone Loss, Age-Related

Japan
Ono Pharmaceutical Co. Ltd

Active, not recruiting

Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Japan
Innovacion y Desarrollo de Estrategias en Salud
BioGaia AB

Completed

L. Reuteri DSM 17938 and L. Reuteri ATCC PTA 6475 in Moderate to Severe Irritable Bowel in Adults (reuteri-IBS)

Irritable Bowel Syndrome

Chile, Mexico
National Taiwan University Hospital

Recruiting

Effectiveness of Caregiver-involved Group-based NDBIs Intervention for Autistic Preschoolers

Autism Spectrum Disorder

Taiwan
Sahlgrenska University Hospital, Sweden

Unknown

Obeticholic Acid in Morbidly Obese Patients and Healthy Volunteers (OCAPUSH)

Obesity

Sweden
Pierre Fabre Medicament

Completed

Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors (OCEANI)

Melanoma | BRAF V600E Unresectable or Metastatic Melanoma | BRAF V600E Metastatic NSCLC

China
Ono Pharmaceutical Co. Ltd
Kyorin Pharmaceutical Co.,Ltd

Completed

Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder

Overactive Bladder

Japan
Ono Pharmaceutical Co. Ltd

Completed

Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Belgium, France, Austria, Germany, Italy, Netherlands, Switzerland, United Kingdom
PMV Pharmaceuticals, Inc
Merck Sharp & Dohme LLC

Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Metastatic Cancer | Advanced Solid Tumor | Endometrial Cancer | Metastatic Solid Tumor | Other Cancer | Advanced Malignant Neoplasm | Locally Advanced

United States, Spain, Korea, Republic of, Australia, France, Germany, Italy, Singapore, United Kingdom
University of Sao Paulo General Hospital

Unknown

Multidisciplinary Health Educational Program Based on Centered People Care Model in Parkinson's Disease (AMPARO)

Parkinson Disease

Brazil
Ono Pharma USA Inc

Completed

Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

Ocular Hypertension (OHT) | Mild Open Angle-glaucoma (OAG)

United States
Ono Pharmaceutical Co. Ltd

Completed

A Phase II Multi-centre, Extension Study to Investigate the Long Term Safety of ONO-2506PO in Patients Diagnosed With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Belgium, France, Germany, Italy, Netherlands, Switzerland, United Kingdom
MedSIR

Terminated

Checkpoint Blockade in COVID-19 Pandemic (COPERNICO)

COVID-19 | Pneumonia, Viral

Spain

Search clinical trials for: ONO-7475

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations